Richard Wilson

Richard Wilson is a seasoned executive in the biopharmaceutical industry, currently serving as Senior Vice President and Primary Focus Lead at Astellas Pharma, where responsibilities include setting gene therapy strategies and managing the gene therapy portfolio. Before this role, Richard held various leadership positions at BioMarin Pharmaceutical Inc., including Executive Director of Product Portfolio Development, successfully contributing to significant product revenues and approvals. Richard's extensive experience also encompasses roles at Innoviva, Theravance, Biochem Pharma, and GlaxoWellcome, focusing on program management, medicinal chemistry, and commercialization strategy. Richard holds an MBA from the University of California, Berkeley, and a B.Sc. in Chemistry from The University of Manchester. Additionally, Richard serves on the boards of AviadoBio, Taysha Gene Therapies, and the Alliance for Regenerative Medicine.